Cubist Systematic Strategies, LLC Essa Pharma Inc. Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.5 - $4.82 $32,292 - $103,764	-21,528 Reduced 38.71%	34,086 $85,000
Q3 2022 Nov 14, 2022	BUY	$1.75 - $3.44 $45,001 - $88,459	25,715 Added 86.01%	55,614 $101,000
Q2 2022 Aug 15, 2022	SELL	$3.15 - $7.94 $37,800 - $95,280	-12,000 Reduced 28.64%	29,899 $94,000
Q1 2022 May 16, 2022	BUY	$6.18 - $14.44 $258,935 - $605,021	41,899 New	41,899 $259,000
Q4 2021 Feb 14, 2022	SELL	$7.8 - $14.38 $271,658 - $500,826	-34,828 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.76 - $29.37 $270,265 - $1.02 Million	34,828 New	34,828 $279,000

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $75.4M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.